Background/Aims: Myostatin is known as a powerful negative regulator of muscle growth playing a key role in skeletal muscle homeostasis. Recent studies revealed that myostatindeficient mice lead to an increase of insulin sensitivity, a decrease of adiposity and a resistance to obesity, showing that myostatin can also impact on metabolism. Thus, myostatin appeared as a potential therapeutic target to treat insulin resistance. Methods: We generated transgenic mice overexpressing Gasp-1, a myostatin inhibitor. Results: Surprisingly, we found that these mice gained weight with age due to an increase in fat mass associated with ectopic fat accumulation. In addition, these mice developed an adipocyte hypertrophy, hyperglycemia, hyperinsulinemia, muscle and hepatic insulin resistance. Understanding the molecular networks controlling this insulin resistance responsiveness in overexpressing Gasp-1 mice is essential. Molecular analyses revealed a deregulation of adipokines and muscle cytokines expression, but also an increase in plasma myostatin levels. The increase in myostatin bioactivity by a positive feedback mechanism in the Tg(Gasp-1) transgenic mice could lead to this combination of phenotypes. Conclusion: Altogether, these data suggested that overexpressing Gasp-1 mice develop most of the symptoms associated with metabolic syndrome and could be a relevant model for the study of obesity or type 2 diabetes.
Introduction
The Transforming Growth Factor β (TGF-β) superfamily members are essential regulators of diverse developmental and homeostatic processes in vertebrates and invertebrates including proliferation, growth, differentiation, migration, and death, as well as physiological processes such as wound healing, and muscle regeneration [1] . More than thirty closely related proteins form this superfamily which can be divided into two main functional groups, the TGF β-like group that induces the receptor-regulated SMAD transcription factors 2 and 3 and the Bone Morphogenetic Proteins (BMP)-like group activating the R-Smads 1, 5 and 8 [2] .
Mutations or alterations in the expression of components of these signaling pathways have been associated with a wide range of human pathologies such as cancer, cardiovascular or muscle disorders [3, 4] . Therefore, several TGF-β members have frequently been assessed as diagnostic or prognostic markers and are also remarkable targets for drug development [5] [6] [7] . TGF-β superfamily signaling is not limited to Smad-mediated pathways, as they can also mediate signaling responses through non-Smad pathways, in particular the Mitogen Activated Protein Kinase (MAPK) pathways, including Extracellular-signal-Regulated Kinase (ERK), p38, and Jun N-terminal Kinase (JNK); the Phosphoinositide 3-Kinase (PI3K)/Akt pathway, and the NF-κB pathway with a crosstalk between canonical and non-canonical TGF-β pathways.
Myostatin (MSTN), also named Growth and Differentiation Factor-8, signals through the TGF-β branch and acts as a powerful negative regulator of muscle growth and plays a key role in skeletal muscle homeostasis. Loss-of-function mutations of the myostatin gene cause in different species increase of skeletal muscle mass resulting from a combination of muscle fiber hypertrophy and hyperplasia [8] [9] [10] [11] while myostatin overexpression is associated with dramatic muscle atrophy in mice and lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin [12, 13] .
In addition to its roles in skeletal muscle growth, many in vivo and in vitro studies have reported that MSTN also regulates metabolism by effects on muscle as well as on other metabolic sites such as adipose tissue or liver. The Mstn -/-mice have a significant reduction in fat accumulation, an increase of insulin sensitivity on both standard chow and high fat diet (HFD). As Guo et al. reported, Mstn -/-mice have increased carbohydrate utilization for energy but the overall lipid utilization per animal did not change [14] . These mice have improved glucose and insulin tolerance and reduced blood glucose and insulin levels [14] . In a hyperinsulinemic-euglycemic clamp study, myostatin deficient mice have increased whole body glucose utilization rate with increases in glucose utilization by white and brown adipose tissue. Treatment with a myostatin antagonist also increased insulin sensitivity during HFD and a resistance to obesity [14] [15] [16] [17] [18] [19] [20] . Interestingly, loss of myostatin partially attenuates the obese and diabetic phenotypes of two mouse models of obesity and diabetes, agouti lethal yellow (A y ) and obese (Lep ob/ob ) [16, [21] [22] [23] [24] . Myostatin activity is mostly regulated by proper proteolytic processing as well as by extracellular inhibitors such as the myostatin propeptide, follistatin, follistatin like 3 (FSTL3), GASP-1 (Growth and Differentiation Factor-Associated Protein Serum 1) and GASP-2 [25] [26] [27] [28] . Transgenic mice overexpressing follistatin or Fstl3 in skeletal muscle have increased skeletal muscle mass due to hypertrophy and hyperplasia and associated with a loss of global fat mass and adipose tissue [29, 30] . Likewise, transgenic overexpression of myostatin propeptide at three months of age prevents diet-induced obesity and insulin resistance [24] . Altogether, these data would suggest that transgenic mice for which myostatin is inhibited or reduced present a resistance to diet induced obesity and are protected against the development of insulin resistance. But compared to these models, overexpressing Gasp-1 -Tg(Gasp-1) -mice present only a myofiber hypertrophy without hyperplasia and without a switch of fiber types [27, 31] . Using protein arrays on satellite cell derived myoblasts from Tg(Gasp-1) mice, we have shown an upregulation of myostatin associated with an activation ERK1/2 signaling pathway and a decrease of Pax7 expression, which could explain the absence of hyperplasia in our model [31] . Moreover, no significant loss of fat mass was observed in Tg(Gasp-1) [27] . To better understand this alteration in metabolism, we characterized in more details young and old Tg(Gasp-1) mice phenotypes. Unexpectedly, we showed that Tg(Gasp-1) animals gained weight with age due to an increase in fat mass associated with ectopic fat accumulation. In addition, Tg(Gasp-1) mice develop an adipocyte hypertrophy, hyperglycemia, hyperinsulinemia and an hepatic steatosis. We show that all these symptoms are linked to an insulin resistance developed by old Tg(Gasp-1) mice.
At the molecular level, we observed a decrease of the muscle-specific glucose transporter GLUT-4 and an upregulation of muscle proinflammatory muscle cytokines and adipokines. Altogether, these data show an insulin resistance phenotype in old Tg(Gasp-1) mice. Finally, the upregulation of myostatin also found in old Tg(Gasp-1) mice reveals that myostatin influences the metabolism of skeletal muscle, adipose tissue and liver, contributing to the development of a metabolic syndrome in old transgenic mice.
Materials and Methods

Animals
Transgenic mice overexpressing Gasp-1 -Tg(Gasp-1) were generated in our team as previously described [27] . Briefly, these mice present an ubiquitously overexpression of GASP-1 which leads to a hypermuscular phenotype. At 3 months of age, these mice present a muscle hypertrophy but no hyperplasia. All mice were bred and housed in the animal facility of University of Limoges under controlled conditions (21°C, 12-h light/12-h dark cycle) with free access to standard mouse chow (RM1 (P) 801151, Special diets services, UK) and tap water. All analyses were realized with young (3-month-old) and old (16-month-old) mice, independently of animal sex.
Phenotypic analyses
To monitor body weight gain, animals were weighed once a week during 16 months. Body composition analysis to determine fat contents was performed on conscious young and old mice, using the EchoMRI-500™ whole body composition analyzer (Echo Medical Systems). Before blooding sampling, WT and Tg(Gasp-1) mice were fasted 16 h. Blood samples were collected in lithium heparin tubes under isofluorane anesthesia following the recommendations of ethical guidelines. At the collection day, blood samples were centrifuged at 4000 rpm for 10 min and plasmas were harvested then analyzed on a KONELAB 30 automat as previously described [32] .
Muscle and adipose tissue weights were measured following dissection of young and old mice. Individual muscles (tibialis anterior, gastrocnemius and soleus) from both sides of the animal were taken and the average weight was used for each muscle.
Histological analyses
Tissues (liver and inguinal adipose tissue) were collected from WT and Tg(Gasp-1) mice at different ages and fixed in formol for 3 days. Then, tissues were embedded in paraffin and sectioned with microtome in 4 µm thickness. The sections were stained with hematoxylin and eosin. Measurements of area/size and quantification of adipocytes were realized with ImageJ software (http://rsbweb.nih.gov/ij/).
Oil Red O solution was prepared in propylene glycol (5 g.l -1 ) and heated at 100°C for 10 min. Frozen liver were sectioned with a cryostat (8 µm thick) and dried for 15 min at 37°C. Sections were then fixed for 10 min in 10% formol /PBS (v/v). To detect neutral lipid accumulation, sections were stained with Oil Red O for 10 min at RT and counterstained with hematoxylin for 2 min at RT.
Immunofluorescence staining protocol
Dissected skeletal muscles (tibialis anterior and gastrocnemius) were frozen in liquid nitrogen-cooled isopentane and stored at -80°C for further analysis or sectioned for immunostaining. The immunofluorescence staining protocol was optimized for GLUT-4 analysis in mouse skeletal muscle. Cryosections were thawed at room temperature, air-dried and fixed for 5 min in 75% acetone 25% ethanol. Subsequently sections were washed 3 times for 5 min in phosphate-buffered saline (PBS). Then, cryosections were blocked for 30 min in blocking buffer consisting of 10% goat serum (NGS, Invitrogen) and 1% bovine serum albumin (BSA) in PBS, at room temperature. GLUT-4 antibody (rabbit IgG, Abcam) was applied to the sections at a dilution of 1:1000 in 5% normal goat serum (NGS, Invitrogen) for 1 h at 37°C. Following primary antibody incubation, sections were washed 3 times for 5 min in Tween-20 1%/PBS. Secondary antibodies were applied to sections for 30 min at 37°C at a dilution of 1:2000 in PBS. GLUT-4 antibody was targeted with goat anti-rabbit IgG 488 (Invitrogen). DAPI (Sigma Aldrich) staining for cell nuclei was added to the secondary antibody at a 0.5 μg·mL −1 concentration. After secondary antibody incubation, sections were washed 3 times for 5 min in Tween-20 1%/PBS. We used the MetaMorph software (Molecular Devices, Sunnyvale, USA) to acquire images with a Leica DMI6000B inverted epifluorescence microscope and to determine the total intensity of GLUT-4 fluorescence for each image. 
Metabolic analyses
For intraperitoneal glucose tolerance tests (IPGTTs), overnight-fasted mice were injected with 20% D-glucose (2 mg.g −1 body weight). Blood glucose levels were monitored using a glucose meter (Roche Applied Science) from 2.5 μl of tail blood at 0, 15, 30, 60 and 120 min after glucose injection. Serum insulin levels were also measured after glucose injection in 10 μl of serum from blood collected from the tip of the tail vein by sandwich ELISA (Rat/Mouse Insulin ELISA kit, Millipore). All measurements were performed in triplicate and data for the standard curve were fitted to a logistic plot with the MARS Data Analysis Software (BMG Labtech) to determine the levels of insulin.
RNA isolation, retrotranscription and qPCR
Total RNA from tissues (tibialis anterior, gastrocnemius, liver and inguinal adipose tissue) were isolated using RNeasy midi kit (Qiagen). Synthesis of cDNA was performed with the High Capacity cDNA Archive kit (Applied Biosystems) to convert 2 μg of total RNA into single-stranded cDNA. Real-time quantitative PCR was performed on an ABI PRISM 7900 Sequence Detection System (Applied Biosystems) in triplicate using 20 ng of cDNA. The total reaction volume of 17.5 μl was made of 8.75 μl 2×Master Mix SYBR Green (Applied Biosystems) and 300 nM of primers (Table 1) . Relative mRNA expression values were calculated by the ΔΔCt method with normalization of each sample to the average change in cycle threshold value of the controls. Western blotting Tissues (tibialis anterior, gastrocnemius, pancreas, liver and inguinal adipose tissue) were crushed, centrifuged (12, 000 × g, 4°C, 20 min) and then lysed in a RIPA buffer (50 mM Tris, pH 8, 150 mM NaCl, 0.1% SDS, 1% NP-40, 0.5% sodium deoxycholate, and protease inhibitors). Proteins were quantified at A 595nm using the Bradford assay (Bio-Rad). Equal amounts of proteins (50 μg) were resolved on SDS-polyacrylamide gels (4-12% gradient, Invitrogen) and then transferred onto 0.2 μm nitrocellulose membranes. Membranes were then blocked using 5% non-fat dry milk (w/v) in TBST 0.1% buffer (50 mM Tris-HCl, 150 mM NaCl, pH 7.4, 0.1% Tween-20) for 1 h at room temperature, followed by incubation with specific primary antibodies overnight at 4°C. Primary antibodies were used at a dilution of 1:1000 for anti-GLUT-4 (MAB1272, R&D Systems) and for anti-GASP-1 (AF2070, R&D Systems) and 1:2000 for anti-GAPDH (AF5718, R&D Systems) antibodies. After 4 washes in TBST 0.1% (v/v), membranes were incubated for 1 h at room temperature with 1:1000 dilution of secondary antibodies: anti-goat IgG horse-radish peroxidase (HRP) conjugate (P0449, Dako) or anti-mouse IgG HRP conjugate (P0447, Dako). After 4 more washes in TBST 0.1% (v/v), immunoblots were developed by enhanced chemiluminescence. The developed films were analyzed using ImageQuant TL software (GE Healthcare). The graphs (densitometric analysis) were obtained using Image J software to quantify GLUT-4 signals normalized with GAPDH signals of three different experiments.
Table 1. List of the primers used for SybrGreen analyses
Genes Primers Sequences GenBank G6pc G6pc-Fwd CCTCGTCTTCAAGTGGATTCTGT NM_008061 G6pc-Rev AAACACCGGAATCCATACGTTGGC Pck1 Pck1-Fwd GAACACAAGGGCAAGATCATC NM_011044 Pck1-Rev TTGCCATCTTTGTCCTTCCG Myh1 Myh1-Fwd AAGCCGATGGGCATCTTCTC NM_030679 Myh1-Rev GGACTTTCCAAGATGCTGCTC Myh2 Myh2-Fwd AATGCAGGGGACGCTGGAGGA NM_001039545 Myh2-Rev CATTCCTCACGGTCTTGGCG Myh4 Myh4-Fwd TCTGGCACCACACCTTCTA NM_010855 Myh4-Rev AGGCATACAGGGACAGCAC Myh7 Myh7-Fwd ACCTACTCGGGCCTCTTCTGC NM_080728 Myh7-Rev AGGGGCCTCGCTCCTCTTCTT Pgc1-α Pgc1-α-Fwd AAGTGTGGAACTCTCTGGAACTG NM_008904 Pgc1-α-Rev GGGTTATCTTGGTTGGCTTTATG FoxO1 FoxO1-Fwd GCGGGCAATTCAATTCGCCACAA NM_019739 FoxO1-Rev CAGCTCTTCTTCGGGGTGATTTT Mstn Mstn-Fwd CAGACCCGTCAAGACTCCTACA NM_010834 Mstn-Rev CCTGCTTCACCACCTTCTTGA Β2m B2m-Fwd CAGTGCCTGGGCTCATGTCAAG NM_009735 B2m-Rev GTTCGGCTTCCCATTCTCC β-actin β-actin-Fwd TCTGGCACCACACCTTCTA NM_007393 β-actin-Rev AGGCATACAGGGACAGCAC Gapdh Gapdh-Fwd TGTGTCCGTCGTGGATCTGA NM_008084 Gapdh-Rev CCTGCTTCACCACCTTCTTGA
Enzyme-linked immunosorbent assay (ELISA) of myostatin and insulin
Myostatin and insulin concentrations for mouse plasmas were determined in a sandwich ELISA (GDF8/ Myostatin ELISA kit, R&D Systems) and (RAT/Mouse Insulin Elisa, Millipore) as previously described [31] . All measurements were performed in triplicate and data for the standard curve were fitted to a logistic plot with the MARS Data Analysis Software (BMG Labtech) to determine the levels of myostatin and insulin.
Cytokines and adipokines antibodies array
Mouse cytokine array (Proteome Profiler Mouse Cytokine Array Kit, R&D Systems) were used following the manufacturer's instructions on mouse tibialis anterior. Mouse Adipokine Array (Proteome Profiler Mouse Adipokine Array Kit, R&D Systems) were used following the manufacturer's instructions on mouse inguinal adipose tissue. The arrays were incubated overnight at 4°C on a rocking platform shaker. The blots were detected using an enhanced chemiluminescence (BM Chemiluminescence Western Blotting Substrate (POD)) (Roche Applied Science) and exposed to a film (GE Healthcare Hyperfilm ECL, GE Healthcare). Densitometric analysis of the array image files were performed using ImageQuant TL software (GE Healthcare).
Statistical analyses
Unless otherwise stated, results are expressed as means ±SEM. Two-way ANOVA was performed to examine the effect of genotype (wild type vs. Tg(Gasp-1)) and the effect of age (3 months-old vs. 16 monthsold) on each parameter. Statistical significance was set at p< 0.05. A minimum of three replicates were performed for each experimental condition.
Results
Overexpression of Gasp-1 leads to an increase of body weight and fat mass with age
The myostatin knockout mice phenotype, i.e. increase of muscle mass and reduced adipose tissue, do not vary with age [16] . As GASP-1 acts as an inhibitor of myostatin, we checked if age-related variations in Tg(Gasp-1) phenotype occurs. First, we compared the body weight of wild type (WT) and Tg(Gasp-1) mice at 3 and 16 months of age. While we observed that both genotypes took weight with aging, this increase was twice more important for aged Tg(Gasp-1) mice than WT (Fig. 1A-B) . One hypothesis is that the body weight gain is related to an increase of global fat mass. Therefore, we calculated the percentage of fat mass of Tg(Gasp-1) mice compared to wild type (Fig. 1C) . Only, an increase of fat mass was observed in old Tg(Gasp-1) mice. No significant difference was observed in young mice (Fig.  1C) . We then tested if this fat mass increase is associated with an increase of muscle mass in old Tg(Gasp-1). Three different muscles representative of each muscular metabolism: the
soleus (slow, oxidative), the tibialis anterior (fast, glycolytic), and the gastrocnemius (both oxidative and glycolytic myofibers) were used. As already shown in young Tg(Gasp-1) mice [27] , we observed an increase about 10% (tibialis) and 18% (gastrocnemius) in Tg(Gasp-1) mice at 16 months of age. No variation was detected in soleus (Fig. 1D ). We observed a decrease of muscle mass associated with aging in WT and transgenic mice but this effect is weaker in muscles of Tg(Gasp-1) mice still presenting the hypermuscular phenotype (Fig.  1D ). To check whether any change in the expression of Gasp-1 occurred during aging, we measured mRNA levels in muscle of both genotypes. No significant difference of endogenous Gasp-1 was observed in WT mice. The overexpression of Gasp-1 was similar in both young and old Tg(Gasp-1) animals ( Fig. 2A) . Moreover, we showed that Gasp-1 overexpression is still found in liver and adipose tissue of old transgenic mice (Fig. 2B) .
Fat mass accumulation is due to both WAT mass increase and ectopic fat deposition in liver
To determine the localization of the fat mass accumulation in old Tg(Gasp-1) mice, we analyzed the relative proportion of epididymal and inguinal masses, two white adipose tissues (WAT), compared to body weight (Fig. 3A) . While the increase of WAT is observed in old wild type and mutant mice compared to young animals, the variation was more important in transgenic mice (Fig. 3A) . Histological analyses revealed an increased adipocyte crosssectional area (CSA) in old Tg(Gasp-1) with a higher incidence of larger adipocytes compared to WT mice (Fig. 3B-D) . In a lesser extent, this distribution was also slightly shifted towards larger adipocytes in young and old transgenic mice (Fig. 3C-D) . Altogether, these results highlighted an adipocyte hypertrophy in Tg(Gasp-1) animals. 
As liver tissue is capable of storing fat mass, we realized an Oil red O staining on liver frozen sections of young and aged WT and Tg(Gasp-1) mice (Fig. 4A) . We observed extensive macrovesicular and microvesicular lipid in hepatocytes of old Tg(Gasp-1), and to a lesser extent in young mutant mice, revealing a hepatic steatosis (Fig. 4A) . To check if the mice developed a hepatic necrosis too, the alanine aminotransferase (ALT C) and asparagine aminotransferase (AST C) enzymes activities were scored in both genotypes ( Table  2) . Aged transgenic mice present a significant higher level of ALT C and AST C enzymes ( Table 2) . These results underlined a global deregulation of fat storage with an increase of fat mass and ectopic fat deposition in aged Tg(Gasp-1) mice. It is well known that an insulin resistance phenotype is associated with an accumulation of triglycerides in liver. Therefore, we measured their levels in liver of young and old mice as well as cholesterol level. No variation of triglycerides and cholesterol levels was observed in young WT and Tg(Gasp-1) mice (Fig. 4B) . However, a significant increase of triglycerides was detected in aged transgenic mice (Fig. 4B) highlighting an alteration of liver metabolism.
Old Tg(Gasp-1) mice develop an insulin resistance
Metabolic syndrome is often associated to insulin resistance phenotype. To test this hypothesis, we performed the intraperitoneal glucose tolerance tests (IPGTTs) and monitoring the serum insulin level. No difference of glucose clearance and insulin sensitivity was observed between young WT and Tg(Gasp-1) mice (Fig. 5A-C) . However, aged Tg(Gasp-1) mice cleared glucose much slower than WT mice at same age, indicating a glucose intolerance in the mutant mice (Fig. 5B ). This glucose intolerance was accompanied by significantly elevated plasma insulin levels during the IPGTT confirming an insulin resistance in Tg(Gasp-1) mice (Fig. 5D) . Altogether, these results assess a glucose homeostasis deregulation and an insulin resistance phenotype in old Tg(Gasp-1) mice.
Deregulation of muscle and liver metabolism in Tg(Gasp-1) mice
The insulin resistance can alterate glucose uptake and muscle metabolism. Thus, we analyzed the expression of the glucose transporter GLUT-4, which is regulated by insulin and found specifically in heart tissue, skeletal muscle, and adipose tissue. Western blot analysis revealed a decrease of 50% of GLUT-4 expression in gastrocnemius muscle of old Tg(Gasp-1) mice compared to WT regardless of age ( Fig. 6A-B) . It was confirmed by immunofluorescence, the total GLUT-4 fluorescence in basal condition decreased significatively in gastrocnemius of old Tg(Gasp-1) mice (Fig. 6C-D) . Moreover, this analysis showed that GLUT-4 seemed more accumulate in fibers rather that plasma membrane in Tg(Gasp-1) compared to WT mice (Fig. 6C) . No difference was observed between young WT and Tg(Gasp-1) mice (data not shown). These data confirmed an alteration of muscle metabolism.
To go further, we decided to test if Pgc1α and FoxO1, potent actors of muscle metabolism, were also altered by the insulin resistance. Thus, we quantified the expression level of these two genes. Pgc1α expression was increased in young Tg(Gasp-1) mice compared to WT (Fig. 7A) . In Tg(Gasp-1) mice, Pgc1α expression was decreased at 16 months of age compared to young mice while no variation of FoxO1 expression was observed (Fig. 7A) (Fig.  7B) . Interestingly, Myh7 is drastically decreased in aged Tg(Gasp-1) mice compared to young transgenic mice (Fig. 7B) .
The insulin resistance can also lead to modifications of liver metabolism. If insulin cannot act on liver, the gluconeogenesis gene expression should increase. We checked the expression of two key enzymes of this metabolic pathway, Phosphoenolpyruvate carboxykinase 1 (Pck1) and Glucose-6-Phosphatase (G6Pc). Pck1 expression was up-regulated by 3-fold in aged Tg(Gasp-1) while a slight increase of G6Pc (1.5-fold) was observed (Fig.  7C ). There was no significant variation of Pck1 and G6Pc expression in young mice (Fig.  7C) . This result confirmed an elevation of hepatic gluconeogenesis which is associated to hepatic insulin resistance and contributes to hyperglycemia (Fig. 7D) . These results showed the development of a metabolic syndrome with aging, responsible for the deregulation of glucose and fat homeostasis in Tg(Gasp-1) mice.
Deregulation of adipokines and muscle cytokines expression in Tg(Gasp-1) mice
The adipose tissue represents an active endocrine organ that releases a large number of bioactive mediators (adipokines) regulating fat mass and glucose homeostasis. To highlight the metabolic syndrome observed in aged Tg(Gasp-1), we analyzed adipokines expression in white adipose tissue. Out of 38 adipokines tested, eight were found upregulated in old mutant mice compared to WT at the same age. Old transgenic mice present a significant increase of C-Reactive Protein, ICAM-1 and Lipocalin-2 as well as growth factors, FGF acidic and HGF, TNF-α, TIMP-1 and Serpin E1 (Fig 8A) . All these overexpressed cytokines are often associated with insulin resistance phenotype. Aged transgenic mice present a significant higher level of ALT C and AST C enzymes, emphasizing a hepatic necrosis. The increase of creatinine, CK and lactate plasma levels in young and old Tg(Gasp-1) confirmed the muscle hypertrophy observed in these animals. An alteration of glucose homeostasis and fat metabolism in the transgenic mice was also revealed by an increase of LDH, triglycerides and glucose levels. Statistical significance was assessed by an ANOVA analysis (*: p value < 0.05; **: p value < 0.005; ***: p value < 0.001).
(n=5 per group in all experiments). Tg: Tg(Gasp-1)
WT 3mo
Tg 3mo WT 16mo Tg 16mo The same study was realized in skeletal muscle which can also participate in glucose and fat homeostasis by secreting proinflammatory cytokines. Tg(Gasp-1) mice present a significant increase of TNF-α, IP-10, the interleukins IL-23, IL-27 and the chemokine CCL5 and to a lesser extent the CXCL 1, 2, 11, 12, IL-17 and TIMP-1 (Fig. 8B) .
One of the most cytokines studied in muscle is myostatin which is known to participate in muscle development and glucose metabolism. Our previous molecular analysis performed on young Tg(Gasp-1) mice revealed an increase of myostatin expression responsible for the absence of hyperplasia [31] . We hypothesized that this upregulation of myostatin could also be implicated in the insulin resistance phenotype observed in old mutant mice. Therefore, we measured myostatin expression on tibialis anterior and found a myostatin expression increase by 5-fold in old Tg(Gasp-1) mice compared to WT mice (Fig. 9A) . In serum, this upregulation is also observed (Fig. 9B) . Altogether, these data would suggest the existence of a crosstalk between muscle, adipose tissue and liver in old Tg(Gasp-1) mice responsible for the insulin resistance in which myostatin played a central role.
Discussion
Myostatin acts as a powerful negative regulator of muscle growth and plays a key role in skeletal muscle homeostasis [8] . Recent studies have shown that Mstn-/-mice leads to an increase of insulin sensitivity, a decrease of adiposity and a resistance to obesity, demonstrating that myostatin can also impact on metabolism [14, 15] . In previous studies, we have shown that transgenic mice overexpressing Gasp-1, a myostatin inhibitor, present a muscle hypertrophy without hyperplasia but no loss of fat mass unlike Mstn-/-mice [27, 31] . To explore in more details the role of Gasp-1 on energetic metabolism, we characterized young and old overexpressing Gasp-1 mice phenotypes in comparison to young and old WT 
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Cellular Physiology and Biochemistry mice. First, we showed that the muscle hypertrophy observed at 3 months is still present in 16-month-old mice. In a unexpected way, we observed that Tg(Gasp-1) animals gained weight with age due to an increase in fat mass associated with ectopic fat accumulation compared to WT and independently of animal sex. This fat mass increase was not due to a feeding alteration. In addition, old Tg(Gasp-1) mice develop an adipocyte hypertrophy, hyperglycemia, hyperinsulinemia and an hepatic steatosis. We showed that these symptoms are linked to insulin resistance in old Tg(Gasp-1) mice. All these aging phenotypes are often associated with metabolic syndrome diseases like obesity or type II diabetes [33] . Since aging promotes phenotypes such as insulin resistance and glucose intolerance, we checked that the observed phenotype is not associated with an endogenous increase in Gasp-1 expression with age. No age-related Gasp-1 increase was found in wildtype mice. In addition, the GASP-1 overexpression remains similar in young and old Tg(Gasp-1) mice.
To understand this insulin resistance phenotype, we investigated the adipose tissue secretome. Indeed, deregulation of adipokines and more precisely inflammatory responses in adipose tissue have been shown as a major mechanism to induce insulin resistance. Several adipokines associated with metabolic syndrome were found increased in adipose tissue of old Tg(Gasp-1) mice like CRP, TIMP, HGF, TNF-α, lipocalin-2, PAI-1 and FGF acidic [34] [35] [36] [37] [38] [39] [40] . CRP inhibits glucose uptake in muscle and liver and its increase could participate to the deregulation of glucose homeostasis, i.e. hyperglycemia, observed in Tg(Gasp-1) mice [41] . Similarly, TIMP and HGF known to increase adipocytes size and triglycerides levels in liver and increased size of pancreatic islets [42, 43] are also overexpressed in Tg(Gasp-1) mice. Altogether, these findings suggested that in our transgenic mice, insulin resistance might result from the alteration of adipokines expression at least in part. Many studies have shown that glucose homeostasis is regulated by a crosstalk between adipose and muscle tissue involving adipokines and muscle cytokines. To check this Cytokine levels were measured in tibialis anterior of 16-month-old mice using the proteome cytokine array. The level of each cytokine was quantified by densitometry. *: p value < 0.05; **: p value < 0.005; ***: p value < 0.001; n=5 per group in all experiments. Tg: Tg(Gasp-1).
Cellular Physiology and Biochemistry potential crosstalk in Tg(Gasp-1) mice, we measured the expression level of a large number of muscle cytokines. We revealed an overexpression of proinflammatory cytokines on the one hand, and an increase of myostatin muscle expression and myostatin plasma levels on the other hand. To explain the muscle phenotype in Tg(Gasp-1) mice, we have already shown an upregulation of myostatin due to a positive feedback mechanism [31] . It is known that absence of myostatin leads to an increase of insulin sensitivity with a reduce of fat mass whereas the myostatin treatment induces an insulin resistance phenotype [44] . Therefore, the myostatin upregulation still present in old Tg(Gasp-1) mice could be responsible for all of these metabolic phenotypes. Indeed, myostatin can inhibit GLUT-4, the muscle glucose transporter [45] . We found a GLUT-4 expression decrease in Tg(Gasp-1) muscle mice as well as an alteration of GLUT-4 membrane translocation, leading to an hyperglycemia. Furthermore, Pgc1α expression which promotes mitochondrial biogenesis and lipid oxidation is negatively regulated by myostatin through AKT or AMPK signaling pathways [15, [46] [47] [48] . In Mstn knockout mice, absence of myostatin induced AMPK/Irisin/PGC1α signaling pathway which improved insulin sensitivity and increased brown adipose tissue expansion [47, 48] . High levels of PGC1α protein expression also promote a fast-to-slow switch fiber type identified by the expression of type I myosin heavy chain Myh7 [48] [49] [50] [51] . In old Tg(Gasp-1) mice, the Pgc1α expression decrease associated with a decrease of Myh7 expression showed a slowto-fast switch fiber type in these mice which confirmed the action of the deregulation of myostatin expression. Myostatin can also act indirectly on organs or tissues involved in glucose homeostasis by modulating the muscle secretome [19, 37] . For example, myostatin promotes the production of pro-inflammatory cytokines such as TNF-α, PAI-1 or CXCL10 [19, 52] . These two cytokines capable to induce an hepatic insulin resistance and pancreatic lipotoxicity are found overexpressed in Tg(Gasp-1) mice as in patients with metabolic disorders [19, 53] . Interestingly, other cytokines are overexpressed in Tg(Gasp-1) animals such the chemokines CXCL11, CXCL2, CCL12 which are regularly found overexpressed in obese or diabetic individuals [33, 53, 54] . Finally, we cannot exclude a direct effect of Gasp-1 on glucose homeostasis since it is ubiquitously overexpressed in our transgenic mice [27] . Its expression is higher in Tg(Gasp-1) adipose tissue and pancreas compared to wild type mice. This overexpression could be responsible for the slight adipocyte hypertrophy observed in Tg(Gasp-1) and thus independently of its action of myostatin. To determine a potential role of Gasp-1 in adipocyte hypertrophy, we are currently generating a Gasp-1 overexpression model on a myostatin deficient background. In addition, as GASP-1 is a secreted protein, its overexpression could affect all the organs involved in glucose homeostasis.
GASP-1 is also known to antagonize GDF-11, another TGF-β which promotes proliferation and differentiation of pancreatic islets [55] . The observed overexpression of Gasp-1 in pancreas could deregulate GDF-11 signaling pathway and disturb the function of 
Cellular Physiology and Biochemistry this tissue. Finally, GASP-1 by its multiple protease inhibitors domains can also participate in the balance between protease and inhibitors highly regulated in pancreas to control the glucose homeostasis [56, 57] . Treatment with recombinant protein GASP-1 on pancreatic cells will present a great interest to determine if Gasp-1 can act independently of myostatin on proliferation, differentiation and insulin secretion capacity of these cells. It would be also interesting to check if overexpression of Gasp-1 impacts on energy expenditure and fuel oxidation via age-dependent mechanisms. Our data revealed that the upregulation of myostatin in overexpressing Gasp-1 mice has significant impact on glucose homeostasis and fat distribution. Aged Tg(Gasp-1) mice present several metabolic defects and could be a relevant model to study insulin resistance mechanisms. These results also demonstrate the complexity of crosstalk between tissues regulating glucose homeostasis and the difficulty to determine the primary tissue responsible from the alteration of glucose metabolism.
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